Telehealth is Here to Stay: New 50 State Survey of Commercial Insurance Laws Reveals Progress
02 December 2019
Two years after Foley’s 2017 Telemedicine and Digital Health Survey uncovered a demand for telemedicine and digital health services, as well as coverage and reimbursement to match the growing demand, Foley explores how each state has responded in its 2019 50-State Telehealth Survey plus District of Columbia (DC) of Commercial Payer Statutes.
The survey found that as of October 2019, 42 states maintain some sort of telehealth commercial payer law, however several of these state laws do not actually require coverage or payment parity.
Foley’s report breaks down variances in telehealth commercial statues state-by-state, including:
- States that have commercial payer statutes in place
- States that have coverage parity or limitations
- States that have payment parity
- States that impose originating site limits
- States that have patient cost shifting protection
- State laws that address telehealth narrow or exclusive networking
- States that require coverage of reimbursement of remote patient monitoring
- States that require coverage of store & forward/asynchronous telemedicine
To read the full survey, download the 2019 report.
Author(s)
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.